Solara Active Pharma: 9th AGM held; 5 resolutions passed including Rs 480 cr RPT with Strides

Solara Active Pharma held its 9th AGM on September 18, 2026, via video conference from 10:30 to 11:40 AM. Five ordinary resolutions were transacted: adoption of audited standalone and consolidated financials for FY ending March 31, 2026, appointment of Mr. Arun Kumar Pillai (retiring by rotation) as Non-Executive Director, ratification of cost auditor remuneration for FY 2026-27, and approval for material related party transactions with Strides Pharma Science up to Rs 480 crores. Auditor reports had no qualifications. Voting results will be declared by September 22, 2026.